About Castor
Castor is a company based in New York (United States) founded in 2012 by Derk Arts. It operates as a SaaS (Software-as-a-Service) and Professional Services. Castor has raised $63.25 million across 4 funding rounds from investors including European Commission, Eight Roads Ventures and F-Prime Capital. Castor offers products and services including Electronic Data Capture (EDC), Electronic Clinical Outcome Assessments (eCOA/ePRO), eConsent, and Decentralized Clinical Trials (DCT). Castor operates in a competitive market with competitors including Medrio, L7 Informatics, MDClone, Clinical Research IO and VivoSense, among others.
- Headquarter New York, United States
- Founders Derk Arts
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$63.25 M (USD)
in 4 rounds
-
Latest Funding Round
$45 M (USD), Series B
Jul 14, 2021
-
Investors
European Commission
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Castor
Castor offers a comprehensive portfolio of products and services, including Electronic Data Capture (EDC), Electronic Clinical Outcome Assessments (eCOA/ePRO), eConsent, and Decentralized Clinical Trials (DCT).
Data from multiple sources is captured and integrated efficiently.
Patient data is managed on a centralized digital platform.
Remote patient recruitment and enrollment are facilitated seamlessly.
Hybrid and decentralized trials are supported with technology.
People of Castor
Unlock access to complete
Unlock access to complete
Funding Insights of Castor
Castor has successfully raised a total of $63.25M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $45 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Castor
Castor has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Commission, Eight Roads Ventures and F-Prime Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Locked | Locked | Locked | |
|
Venture capital investment and global platform support for startups.
|
Locked | Locked | Locked | |
|
Early-stage investments in tech sectors are managed by the firm.
|
Locked | Locked | Locked |
Investor details for Castor
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Castor
Investment portfolio details for Castor
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Castor
Detailed financials for Castor
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Castor Comparisons
Peer comparison for Castor
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Castor
Castor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medrio, L7 Informatics, MDClone, Clinical Research IO and VivoSense, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based eClinical software for clinical trials is provided.
|
|
| Locked | Locked | Locked |
Clinical trial workflow management software is provided for laboratories.
|
|
| Locked | Locked | Locked |
Provider of software that creates synthetic medical records for fictitious patients
|
|
| Locked | Locked | Locked |
Clinical trial management software is provided for research sites.
|
|
| Locked | Locked | Locked |
Wearable sensor research analysis platform
|
Detailed competitors of Castor
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Castor
Complete news archive for Castor
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Castor
Castor was founded in 2012 and raised its 1st funding round 5 years after it was founded.
Castor is headquartered in New York, United States. It is registered at New York, New York, United States.
Derk Arts is the current CEO of Castor. They have also founded this company.
Castor is a funded company, having raised a total of $63.25M across 4 funding rounds to date.
Castor is established as a provider of eClinical solutions for clinical trials and real-world evidence studies. The platform is designed to simplify workflows and accelerate research breakthroughs in the healthcare sector. Tools for electronic data capture, patient outcome assessments, consent management, and decentralized trials are offered. Scalable solutions are provided to biotech, pharma, medical device companies, and academic researchers. Compliance with global standards like GDPR and HIPAA is ensured, supporting secure data management across the trial lifecycle.
Castor's top competitors include L7 Informatics, MDClone and Medrio.
Castor offers Electronic Data Capture (EDC), Electronic Clinical Outcome Assessments (eCOA/ePRO), eConsent, and Decentralized Clinical Trials (DCT).
Castor has 5 investors. Key investors include European Commission, Eight Roads Ventures, F-Prime Capital, Two Sigma Ventures, and Inkef.